摘要
Objective:To observe the effects of acupuncture at different times on plasma thromboxane(TXB2) and prostaglandin 6-Keto-PGF1a(6-K-P) in patients with ischemic cerebrovascular disease.Methods:Totally 90 patients were randomly divided into a group acupunctured at 7-9 am,a group acupunctured at 3-5 pm and a drug control group,with 30 cases in each group.The contents of plasma TXB2 and 6-K-P from venous blood before treatment were compared with those 15 days after treatment.Results:The plasma TXB2 levels of the two acupuncture groups were obviously lower than those before treatment(P<0.05,P<0.01) ,but the 6-K-P levels of both the acupuncture groups were remarkably higher than those before treatment(P<0.05,P<0.01) . And the TXB2 level in the 3-5 pm acupuncture group was obviously lower than that in the 7-9 am acupuncture group(P<0.05) ,and the 6-K-P level of the former was obviously higher than that of the latter(P<0.05) .Conclusion:Acupuncture can promote functional recovery in patients with ischemic cerebrovascular disease and enhance their survival quality.
Objective：To observe the effects of acupuncture at different times on plasma thromboxane（TXB2） and prostaglandin 6-Keto-PGF1a（6-K-P） in patients with ischemic cerebrovascular disease.Methods：Totally 90 patients were randomly divided into a group acupunctured at 7-9 am,a group acupunctured at 3-5 pm and a drug control group,with 30 cases in each group.The contents of plasma TXB2 and 6-K-P from venous blood before treatment were compared with those 15 days after treatment.Results：The plasma TXB2 levels of the two acupuncture groups were obviously lower than those before treatment（P〈0.05,P〈0.01） ,but the 6-K-P levels of both the acupuncture groups were remarkably higher than those before treatment（P〈0.05,P〈0.01） . And the TXB2 level in the 3-5 pm acupuncture group was obviously lower than that in the 7-9 am acupuncture group（P〈0.05） ,and the 6-K-P level of the former was obviously higher than that of the latter（P〈0.05） .Conclusion：Acupuncture can promote functional recovery in patients with ischemic cerebrovascular disease and enhance their survival quality.
